σ-1 Receptor Stimulation Protects Against Pressure-induced Damage Through InsR-MAPK Signaling in Human Trabecular Meshwork Cells
Overview
Affiliations
The purpose of the present study was to investigate the protective effect of the σ-1 receptor (Sig-1R) agonist (+)‑pentazocin (PTZ) on pressure-induced apoptosis and death of human trabecular meshwork cells (hTMCs). The expression levels of Sig‑1R and insulin receptor (InsR) were examined in hTMCs. Cells were cultured under a pressure of 0, 20, 40, 60 and 80 mmHg for 48 h, and under 80 mmHg for 44 h, after which the cells were treated with (+)‑PTZ (20 µM), N-(2-(3,4-dichlorophenyl)ethyl)-N‑methyl-2‑(dimethylamino) ethylamine (BD‑1063; 20 µM) administered 30 min prior to (+)‑PTZ, or BD‑1063 (20 µM) and then exposed to 80 mmHg again until the 48 h time‑point. The changes of the cells were observed by optical and electron microscopy, the apoptosis and death of hTMCs were detected by ethidium bromide/acridine orange dual staining assay and the expression of Sig‑1R and InsR by reverse transcription‑quantitative polymerase chain reaction and western blot analysis. The phosphorylation of extracellular signal‑regulated kinase (ERK), an important downstream protein of the InsR‑mitogen‑activated protein kinases (MAPK) signaling pathway, was also detected by western blot analysis when (+)‑PTZ and BD‑1063 were added to the 80 mmHg‑treated cells. Sig‑1Rs and InsRs were expressed in hTMCs. The apoptosis and death of hTMCs increased from 40 mmHg with 50% cell death when the pressure was at 80 mmHg and the structure of the cells noticeably changed. The expression of Sig‑1R and InsR increased along with the elevation of pressure. (+)‑PTZ decreased the apoptosis and death of hTMCs and increased the expression of Sig‑1R and InsR, and the phosphorylation of ERK. Such effects were blocked by BD‑1063. The present study suggested that Sig‑1R agonist (+)‑PTZ can protect hTMCs from pressure‑induced apoptosis and death by activating InsR and the MAPK signal pathway.
Tran M, Medveczki T, Besztercei B, Torok G, Szabo A, Gasull X Life (Basel). 2023; 13(7).
PMID: 37511956 PMC: 10381521. DOI: 10.3390/life13071581.
Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells.
Hodrea J, Tran M, Besztercei B, Medveczki T, Szabo A, Orfi L Int J Mol Sci. 2023; 24(14).
PMID: 37511406 PMC: 10380218. DOI: 10.3390/ijms241411646.
Zhang K, Hu Y, Li R, Li T Front Immunol. 2022; 13:966814.
PMID: 36389688 PMC: 9664004. DOI: 10.3389/fimmu.2022.966814.
Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms.
Xu Z, Lei Y, Qin H, Zhang S, Li P, Yao K Int J Mol Sci. 2022; 23(14).
PMID: 35886921 PMC: 9321618. DOI: 10.3390/ijms23147572.
Neuroinflammation in Primary Open-Angle Glaucoma.
Vernazza S, Tirendi S, Bassi A, Traverso C, Sacca S J Clin Med. 2020; 9(10).
PMID: 33007927 PMC: 7601106. DOI: 10.3390/jcm9103172.